	bcr_subject_code	subject_gender	subject_race	pharm_tx_mitotane_indicator	pharm_tx_mitotane_theraputic_at_rec	pharm_tx_mitotane_for_macro_disease	pharm_tx_mitotane_theraputic_macro	pharm_tx_mitotane_theraputic_at_prog	ct_scan_preop_results.1	weiss_score_overall	mitoses_per_50_hpf	metastatic_tumor_site.1	history_adrenal_hormone_excess	history_basis_adrenal_hormone_dx	age_upon_diagnosis	atypical_mitotic_figures	cytoplasm_presence_less_than_equal_25_percent	diffuse_architecture	invasion_of_tumor_capsule	mitotic_rate	necrosis	nuclear_grade_III_IV	ret	sdha	sdhaf2_sdh5	sdhb	sdhc	sdhd	sinusoid_invasion	tmem127	vhl	weiss_venous_invasion
1	TCGA-OR-A5J1	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	3	5	[Not Available]	Mineralocorticoids	[Unknown]	58	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
2	TCGA-OR-A5J2	FEMALE	WHITE	YES	[Not Available]	YES	[Unknown]	[Unknown]	Lung Involvement	8	0	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	44	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
3	TCGA-OR-A5J3	FEMALE	WHITE	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	Vena Cava Involvement/thrombus	6	6	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	23	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
4	TCGA-OR-A5J4	FEMALE	WHITE	YES	[Not Available]	YES	[Unknown]	[Unknown]	Lung Involvement	6	77	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	23	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
5	TCGA-OR-A5J5	MALE	WHITE	YES	[Not Available]	YES	[Unknown]	[Unknown]	Retroperitoneal Lymph Node Involvement	6	3	[Not Available]	None	[Not Available]	30	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
6	TCGA-OR-A5J6	FEMALE	BLACK OR AFRICAN AMERICAN	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	29	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
7	TCGA-OR-A5J7	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	6	3	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	30	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
8	TCGA-OR-A5J8	MALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	8	15	[Not Available]	Cortisol	Biochemical Assessment	66	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
9	TCGA-OR-A5J9	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	6	6	[Not Available]	None	[Not Available]	22	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
10	TCGA-OR-A5JA	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	9	90	Retroperitoneum	Androgen	Both Clinical and Biochemical Assessments	53	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
11	TCGA-OR-A5JB	MALE	WHITE	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	7	15	brain	None	[Not Available]	52	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
12	TCGA-OR-A5JC	MALE	WHITE	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	8	24	[Not Available]	Estrogen	Biochemical Assessment	37	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
13	TCGA-OR-A5JD	FEMALE	WHITE	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	3	4	[Not Available]	None	[Not Available]	57	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
14	TCGA-OR-A5JE	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	8	60	[Not Available]	Cortisol	Biochemical Assessment	17	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
15	TCGA-OR-A5JF	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	4	[Not Available]	Cortisol	Biochemical Assessment	69	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
16	TCGA-OR-A5JG	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Retroperitoneal Lymph Node Involvement	9	100	left cervical lymph node	Cortisol	Both Clinical and Biochemical Assessments	61	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
17	TCGA-OR-A5JH	FEMALE	WHITE	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	1	[Not Available]	None	[Not Available]	32	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
18	TCGA-OR-A5JI	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	1	[Not Available]	None	[Not Available]	22	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
19	TCGA-OR-A5JJ	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	9	50	[Not Available]	None	[Not Available]	65	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
20	TCGA-OR-A5JK	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	8	4	[Not Available]	None	[Not Available]	49	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
21	TCGA-OR-A5JL	FEMALE	WHITE	YES	[Unknown]	[Not Available]	[Not Available]	[Not Available]	Normal	5	6	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	36	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
22	TCGA-OR-A5JM	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Liver Involvement	9	90	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	25	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
23	TCGA-OR-A5JO	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	2	[Not Available]	None	[Not Available]	26	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
24	TCGA-OR-A5JP	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	6	13	[Not Available]	None	[Not Available]	40	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
25	TCGA-OR-A5JQ	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	4	3	[Not Available]	None	[Not Available]	26	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
26	TCGA-OR-A5JR	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	45	[Not Available]	[Not Available]	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	[Not Available]	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
27	TCGA-OR-A5JS	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	35	[Not Available]	None	[Not Available]	65	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
28	TCGA-OR-A5JT	FEMALE	WHITE	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	Normal	[Not Available]	5	[Not Available]	Cortisol	Biochemical Assessment	65	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
29	TCGA-OR-A5JU	FEMALE	WHITE	YES	[Not Available]	NO	[Not Available]	[Not Available]	Normal	[Not Available]	10	[Not Available]	None	[Not Available]	58	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
30	TCGA-OR-A5JV	MALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	55	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	[Not Available]	Necrosis Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
31	TCGA-OR-A5JW	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	47	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
32	TCGA-OR-A5JX	MALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	5	[Not Available]	None	[Not Available]	50	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
33	TCGA-OR-A5JY	FEMALE	WHITE	YES	[Not Available]	YES	NO	[Not Available]	Vena Cava Involvement/thrombus	[Not Available]	60	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	68	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
34	TCGA-OR-A5JZ	MALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	[Not Available]	5	[Not Available]	None	[Not Available]	60	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
35	TCGA-OR-A5K0	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	8	[Not Available]	Cortisol	Biochemical Assessment	69	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
36	TCGA-OR-A5K1	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Retroperitoneal Lymph Node Involvement	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	48	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
37	TCGA-OR-A5K2	FEMALE	WHITE	YES	NO	YES	[Unknown]	[Unknown]	Normal	[Not Available]	51	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	32	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
38	TCGA-OR-A5K3	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	53	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	[Not Available]	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
39	TCGA-OR-A5K4	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Vena Cava Involvement/thrombus	[Not Available]	2	[Not Available]	None	[Not Available]	64	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
40	TCGA-OR-A5K5	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	[Not Available]	31	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	59	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
41	TCGA-OR-A5K6	FEMALE	WHITE	YES	[Not Available]	YES	YES	YES	Normal	5	7	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	56	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
42	TCGA-OR-A5K8	MALE	WHITE	YES	[Not Available]	NO	[Not Available]	[Not Available]	Normal	4	7	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	39	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
43	TCGA-OR-A5K9	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	61	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
44	TCGA-OR-A5KB	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	7	129	[Not Available]	None	[Not Available]	61	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
45	TCGA-OR-A5KO	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Liver Involvement	9	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	39	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
46	TCGA-OR-A5KP	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	6	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	45	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
47	TCGA-OR-A5KQ	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	[Not Available]	[Not Available]	Androgen|Mineralocorticoids	Both Clinical and Biochemical Assessments	20	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
48	TCGA-OR-A5KS	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	0	[Not Available]	None	[Not Available]	72	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
49	TCGA-OR-A5KT	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	2	1	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	44	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
50	TCGA-OR-A5KU	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	2	[Not Available]	[Not Available]	Mineralocorticoids	Both Clinical and Biochemical Assessments	37	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
51	TCGA-OR-A5KV	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Retroperitoneal Lymph Node Involvement	3	[Not Available]	[Not Available]	Androgen|Cortisol	Biochemical Assessment	17	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
52	TCGA-OR-A5KW	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Retroperitoneal Lymph Node Involvement	[Not Available]	10	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	55	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
53	TCGA-OR-A5KX	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	[Not Available]	[Not Available]	[Unknown]	[Not Available]	25	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
54	TCGA-OR-A5KY	FEMALE	WHITE	YES	[Not Available]	YES	YES	NO	Lung Involvement	3	5	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	23	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
55	TCGA-OR-A5KZ	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	8	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	42	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
56	TCGA-OR-A5L1	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	37	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
57	TCGA-OR-A5L2	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	30	[Not Available]	[Unknown]	[Not Available]	83	Atypical Mitotic Figures Present	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
58	TCGA-OR-A5L3	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	67	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
59	TCGA-OR-A5L4	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	48	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
60	TCGA-OR-A5L5	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	4	15	[Not Available]	Androgen|Estrogen	Biochemical Assessment	77	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
61	TCGA-OR-A5L6	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	7	23	[Not Available]	Androgen	Biochemical Assessment	60	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
62	TCGA-OR-A5L8	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	4	[Not Available]	[Not Available]	Mineralocorticoids|Cortisol	Both Clinical and Biochemical Assessments	36	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
63	TCGA-OR-A5L9	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	3	5	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	53	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
64	TCGA-OR-A5LA	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	5	1	[Not Available]	None	[Not Available]	52	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
65	TCGA-OR-A5LB	MALE	WHITE	YES	[Not Available]	YES	YES	YES	Lung Involvement	4	8	Vena cava and left atrium of the heart	Androgen	Biochemical Assessment	59	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
66	TCGA-OR-A5LC	FEMALE	WHITE	YES	[Not Available]	YES	NO	[Not Available]	Liver Involvement	3	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	71	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
67	TCGA-OR-A5LD	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	5	[Not Available]	[Not Available]	None	[Not Available]	52	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
68	TCGA-OR-A5LE	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	5	[Not Available]	[Not Available]	[Unknown]	[Not Available]	14	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
69	TCGA-OR-A5LF	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	5	[Not Available]	[Not Available]	None	[Not Available]	74	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
70	TCGA-OR-A5LG	MALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	6	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	46	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
71	TCGA-OR-A5LH	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	5	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	36	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
72	TCGA-OR-A5LI	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	6	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	42	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
73	TCGA-OR-A5LJ	FEMALE	WHITE	YES	[Not Available]	YES	[Not Available]	[Not Available]	Lung Involvement	8	10	Lymph nodes	Androgen|Cortisol	Both Clinical and Biochemical Assessments	54	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
74	TCGA-OR-A5LK	MALE	[Not Evaluated]	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	5	7	[Not Available]	None	[Not Available]	62	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
75	TCGA-OR-A5LL	FEMALE	[Not Evaluated]	YES	YES	NO	[Not Available]	[Not Available]	Normal	7	15	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	75	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
76	TCGA-OR-A5LM	MALE	[Not Evaluated]	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	18	[Not Available]	Estrogen	Both Clinical and Biochemical Assessments	23	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
77	TCGA-OR-A5LN	FEMALE	[Not Evaluated]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	6	6	[Not Available]	None	[Not Available]	31	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
78	TCGA-OR-A5LO	FEMALE	[Not Evaluated]	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	12	[Not Available]	Androgen|Estrogen	Both Clinical and Biochemical Assessments	61	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
79	TCGA-OR-A5LP	FEMALE	[Not Evaluated]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	5	0	[Not Available]	None	[Not Available]	37	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
80	TCGA-OR-A5LR	FEMALE	[Not Evaluated]	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	6	[Not Available]	Mineralocorticoids	Both Clinical and Biochemical Assessments	30	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
81	TCGA-OR-A5LS	FEMALE	[Not Evaluated]	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	6	7	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	34	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
82	TCGA-OR-A5LT	MALE	[Not Evaluated]	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	8	10	[Not Available]	None	[Not Available]	57	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
83	TCGA-OU-A5PI	FEMALE	WHITE	YES	[Not Available]	NO	[Not Available]	[Not Available]	Lung Involvement	2	[Not Available]	[Not Available]	None	[Not Available]	53	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	RET Negative	[Not Evaluated]	[Not Evaluated]	[Not Evaluated]	[Not Evaluated]	[Not Evaluated]	Sinusoid Invasion Absent	[Not Evaluated]	[Not Evaluated]	Venous Invasion Absent
84	TCGA-P6-A5OF	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Vena Cava Involvement/thrombus	4	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	55	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
85	TCGA-P6-A5OG	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	4	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	45	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
86	TCGA-P6-A5OH	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	[Not Available]	[Not Available]	[Unknown]	[Not Available]	59	[Not Available]	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	[Not Available]	[Not Available]	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
87	TCGA-PA-A5YG	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	51	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
88	TCGA-PK-A5H8	MALE	WHITE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	7	9	[Not Available]	[Not Available]	[Not Available]	42	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
89	TCGA-PK-A5H9	FEMALE	ASIAN	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	2	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	27	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
90	TCGA-PK-A5HA	MALE	[Unknown]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	8	[Not Available]	[Not Available]	None	[Not Available]	63	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
91	TCGA-PK-A5HB	MALE	[Unknown]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	63	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
92	TCGA-PK-A5HC	FEMALE	ASIAN	YES	[Not Available]	[Not Available]	YES	YES	Vena Cava Involvement/thrombus	[Discrepancy]	19	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	44	[Not Available]	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
93	bcr_subject_code	subject_gender	subject_race	pharm_tx_mitotane_indicator	pharm_tx_mitotane_theraputic_at_rec	pharm_tx_mitotane_for_macro_disease	pharm_tx_mitotane_theraputic_macro	pharm_tx_mitotane_theraputic_at_prog	ct_scan_preop_results.1	weiss_score_overall	mitoses_per_50_hpf	metastatic_tumor_site.1	history_adrenal_hormone_excess	history_basis_adrenal_hormone_dx	age_upon_diagnosis	atypical_mitotic_figures	cytoplasm_presence_less_than_equal_25_percent	diffuse_architecture	invasion_of_tumor_capsule	mitotic_rate	necrosis	nuclear_grade_III_IV	ret	sdha	sdhaf2_sdh5	sdhb	sdhc	sdhd	sinusoid_invasion	tmem127	vhl	weiss_venous_invasion
94	CDE_ID:2673794	CDE_ID:2200604	CDE_ID:2192199	CDE_ID:3646372	CDE_ID:3646379	CDE_ID:3646385	CDE_ID:3646380	CDE_ID:3646382	CDE_ID:3151439	CDE_ID:3648744	CDE_ID:3646391	CDE_ID:2961431	CDE_ID:3646386	CDE_ID:3646387	CDE_ID:2006657	CDE_ID:3648743	CDE_ID:3648743	CDE_ID:3648743	CDE_ID:3648743	CDE_ID:3648743	CDE_ID:3648743	CDE_ID:3648743	CDE_ID:3121628	CDE_ID:3121628	CDE_ID:3121628	CDE_ID:3121628	CDE_ID:3121628	CDE_ID:3121628	CDE_ID:3648743	CDE_ID:3121628	CDE_ID:3121628	CDE_ID:3648743
95	TCGA-OR-A5J1	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	3	5	[Not Available]	Mineralocorticoids	[Unknown]	58	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
96	TCGA-OR-A5J2	FEMALE	WHITE	YES	[Not Available]	YES	[Unknown]	[Unknown]	Lung Involvement	8	0	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	44	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
97	TCGA-OR-A5J3	FEMALE	WHITE	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	Vena Cava Involvement/thrombus	6	6	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	23	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
98	TCGA-OR-A5J4	FEMALE	WHITE	YES	[Not Available]	YES	[Unknown]	[Unknown]	Lung Involvement	6	77	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	23	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
99	TCGA-OR-A5J5	MALE	WHITE	YES	[Not Available]	YES	[Unknown]	[Unknown]	Retroperitoneal Lymph Node Involvement	6	3	[Not Available]	None	[Not Available]	30	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
100	TCGA-OR-A5J6	FEMALE	BLACK OR AFRICAN AMERICAN	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	29	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
101	TCGA-OR-A5J7	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	6	3	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	30	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
102	TCGA-OR-A5J8	MALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	8	15	[Not Available]	Cortisol	Biochemical Assessment	66	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
103	TCGA-OR-A5J9	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	6	6	[Not Available]	None	[Not Available]	22	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
104	TCGA-OR-A5JA	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	9	90	Retroperitoneum	Androgen	Both Clinical and Biochemical Assessments	53	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
105	TCGA-OR-A5JB	MALE	WHITE	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	7	15	brain	None	[Not Available]	52	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
106	TCGA-OR-A5JC	MALE	WHITE	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	8	24	[Not Available]	Estrogen	Biochemical Assessment	37	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
107	TCGA-OR-A5JD	FEMALE	WHITE	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	3	4	[Not Available]	None	[Not Available]	57	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
108	TCGA-OR-A5JE	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	8	60	[Not Available]	Cortisol	Biochemical Assessment	17	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
109	TCGA-OR-A5JF	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	4	[Not Available]	Cortisol	Biochemical Assessment	69	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
110	TCGA-OR-A5JG	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Retroperitoneal Lymph Node Involvement	9	100	left cervical lymph node	Cortisol	Both Clinical and Biochemical Assessments	61	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
111	TCGA-OR-A5JH	FEMALE	WHITE	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	1	[Not Available]	None	[Not Available]	32	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
112	TCGA-OR-A5JI	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	1	[Not Available]	None	[Not Available]	22	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
113	TCGA-OR-A5JJ	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	9	50	[Not Available]	None	[Not Available]	65	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
114	TCGA-OR-A5JK	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	8	4	[Not Available]	None	[Not Available]	49	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
115	TCGA-OR-A5JL	FEMALE	WHITE	YES	[Unknown]	[Not Available]	[Not Available]	[Not Available]	Normal	5	6	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	36	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
116	TCGA-OR-A5JM	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Liver Involvement	9	90	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	25	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
117	TCGA-OR-A5JO	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	2	[Not Available]	None	[Not Available]	26	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
118	TCGA-OR-A5JP	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	6	13	[Not Available]	None	[Not Available]	40	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
119	TCGA-OR-A5JQ	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	4	3	[Not Available]	None	[Not Available]	26	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
120	TCGA-OR-A5JR	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	45	[Not Available]	[Not Available]	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	[Not Available]	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
121	TCGA-OR-A5JS	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	35	[Not Available]	None	[Not Available]	65	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
122	TCGA-OR-A5JT	FEMALE	WHITE	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	Normal	[Not Available]	5	[Not Available]	Cortisol	Biochemical Assessment	65	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
123	TCGA-OR-A5JU	FEMALE	WHITE	YES	[Not Available]	NO	[Not Available]	[Not Available]	Normal	[Not Available]	10	[Not Available]	None	[Not Available]	58	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
124	TCGA-OR-A5JV	MALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	55	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	[Not Available]	Necrosis Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
125	TCGA-OR-A5JW	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	47	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
126	TCGA-OR-A5JX	MALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	5	[Not Available]	None	[Not Available]	50	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
127	TCGA-OR-A5JY	FEMALE	WHITE	YES	[Not Available]	YES	NO	[Not Available]	Vena Cava Involvement/thrombus	[Not Available]	60	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	68	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
128	TCGA-OR-A5JZ	MALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	[Not Available]	5	[Not Available]	None	[Not Available]	60	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
129	TCGA-OR-A5K0	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	8	[Not Available]	Cortisol	Biochemical Assessment	69	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Absent
130	TCGA-OR-A5K1	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Retroperitoneal Lymph Node Involvement	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	48	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
131	TCGA-OR-A5K2	FEMALE	WHITE	YES	NO	YES	[Unknown]	[Unknown]	Normal	[Not Available]	51	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	32	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
132	TCGA-OR-A5K3	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	53	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	[Not Available]	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
133	TCGA-OR-A5K4	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Vena Cava Involvement/thrombus	[Not Available]	2	[Not Available]	None	[Not Available]	64	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
134	TCGA-OR-A5K5	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	[Not Available]	31	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	59	[Not Available]	[Not Available]	[Not Available]	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
135	TCGA-OR-A5K6	FEMALE	WHITE	YES	[Not Available]	YES	YES	YES	Normal	5	7	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	56	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
136	TCGA-OR-A5K8	MALE	WHITE	YES	[Not Available]	NO	[Not Available]	[Not Available]	Normal	4	7	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	39	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
137	TCGA-OR-A5K9	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	61	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
138	TCGA-OR-A5KB	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	7	129	[Not Available]	None	[Not Available]	61	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
139	TCGA-OR-A5KO	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Liver Involvement	9	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	39	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
140	TCGA-OR-A5KP	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	6	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	45	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
141	TCGA-OR-A5KQ	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	[Not Available]	[Not Available]	Androgen|Mineralocorticoids	Both Clinical and Biochemical Assessments	20	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
142	TCGA-OR-A5KS	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	0	[Not Available]	None	[Not Available]	72	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
143	TCGA-OR-A5KT	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	2	1	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	44	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
144	TCGA-OR-A5KU	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	2	[Not Available]	[Not Available]	Mineralocorticoids	Both Clinical and Biochemical Assessments	37	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
145	TCGA-OR-A5KV	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Retroperitoneal Lymph Node Involvement	3	[Not Available]	[Not Available]	Androgen|Cortisol	Biochemical Assessment	17	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
146	TCGA-OR-A5KW	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Retroperitoneal Lymph Node Involvement	[Not Available]	10	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	55	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
147	TCGA-OR-A5KX	FEMALE	WHITE	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	[Not Available]	[Not Available]	[Unknown]	[Not Available]	25	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
148	TCGA-OR-A5KY	FEMALE	WHITE	YES	[Not Available]	YES	YES	NO	Lung Involvement	3	5	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	23	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
149	TCGA-OR-A5KZ	MALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	8	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	42	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
150	TCGA-OR-A5L1	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	37	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
151	TCGA-OR-A5L2	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	30	[Not Available]	[Unknown]	[Not Available]	83	Atypical Mitotic Figures Present	[Not Available]	[Not Available]	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
152	TCGA-OR-A5L3	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	67	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
153	TCGA-OR-A5L4	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	48	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
154	TCGA-OR-A5L5	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	4	15	[Not Available]	Androgen|Estrogen	Biochemical Assessment	77	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
155	TCGA-OR-A5L6	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	7	23	[Not Available]	Androgen	Biochemical Assessment	60	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
156	TCGA-OR-A5L8	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	4	[Not Available]	[Not Available]	Mineralocorticoids|Cortisol	Both Clinical and Biochemical Assessments	36	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
157	TCGA-OR-A5L9	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	3	5	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	53	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
158	TCGA-OR-A5LA	FEMALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	5	1	[Not Available]	None	[Not Available]	52	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
159	TCGA-OR-A5LB	MALE	WHITE	YES	[Not Available]	YES	YES	YES	Lung Involvement	4	8	Vena cava and left atrium of the heart	Androgen	Biochemical Assessment	59	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
160	TCGA-OR-A5LC	FEMALE	WHITE	YES	[Not Available]	YES	NO	[Not Available]	Liver Involvement	3	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	71	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
161	TCGA-OR-A5LD	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	5	[Not Available]	[Not Available]	None	[Not Available]	52	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
162	TCGA-OR-A5LE	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	5	[Not Available]	[Not Available]	[Unknown]	[Not Available]	14	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
163	TCGA-OR-A5LF	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	5	[Not Available]	[Not Available]	None	[Not Available]	74	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
164	TCGA-OR-A5LG	MALE	WHITE	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	6	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	46	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
165	TCGA-OR-A5LH	FEMALE	WHITE	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	3	5	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	36	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
166	TCGA-OR-A5LI	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	6	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	42	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
167	TCGA-OR-A5LJ	FEMALE	WHITE	YES	[Not Available]	YES	[Not Available]	[Not Available]	Lung Involvement	8	10	Lymph nodes	Androgen|Cortisol	Both Clinical and Biochemical Assessments	54	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
168	TCGA-OR-A5LK	MALE	[Not Evaluated]	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	5	7	[Not Available]	None	[Not Available]	62	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
169	TCGA-OR-A5LL	FEMALE	[Not Evaluated]	YES	YES	NO	[Not Available]	[Not Available]	Normal	7	15	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	75	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
170	TCGA-OR-A5LM	MALE	[Not Evaluated]	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	18	[Not Available]	Estrogen	Both Clinical and Biochemical Assessments	23	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
171	TCGA-OR-A5LN	FEMALE	[Not Evaluated]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	6	6	[Not Available]	None	[Not Available]	31	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
172	TCGA-OR-A5LO	FEMALE	[Not Evaluated]	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	12	[Not Available]	Androgen|Estrogen	Both Clinical and Biochemical Assessments	61	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
173	TCGA-OR-A5LP	FEMALE	[Not Evaluated]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	5	0	[Not Available]	None	[Not Available]	37	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
174	TCGA-OR-A5LR	FEMALE	[Not Evaluated]	YES	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Normal	7	6	[Not Available]	Mineralocorticoids	Both Clinical and Biochemical Assessments	30	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
175	TCGA-OR-A5LS	FEMALE	[Not Evaluated]	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	6	7	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	34	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
176	TCGA-OR-A5LT	MALE	[Not Evaluated]	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	Normal	8	10	[Not Available]	None	[Not Available]	57	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
177	TCGA-OU-A5PI	FEMALE	WHITE	YES	[Not Available]	NO	[Not Available]	[Not Available]	Lung Involvement	2	[Not Available]	[Not Available]	None	[Not Available]	53	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Absent	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	RET Negative	[Not Evaluated]	[Not Evaluated]	[Not Evaluated]	[Not Evaluated]	[Not Evaluated]	Sinusoid Invasion Absent	[Not Evaluated]	[Not Evaluated]	Venous Invasion Absent
178	TCGA-P6-A5OF	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Vena Cava Involvement/thrombus	4	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	55	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Venous Invasion Present
179	TCGA-P6-A5OG	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Lung Involvement	4	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	45	Atypical Mitotic Figures Absent	Cytoplasm presence <= 25% Present	Diffuse Architecture Absent	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Absent
180	TCGA-P6-A5OH	FEMALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	[Not Available]	[Not Available]	[Unknown]	[Not Available]	59	[Not Available]	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	[Not Available]	[Not Available]	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
181	TCGA-PA-A5YG	MALE	WHITE	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Normal	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	51	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
182	TCGA-PK-A5H8	MALE	WHITE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	7	9	[Not Available]	[Not Available]	[Not Available]	42	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
183	TCGA-PK-A5H9	FEMALE	ASIAN	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	2	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	27	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Available]	Venous Invasion Present
184	TCGA-PK-A5HA	MALE	[Unknown]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	8	[Not Available]	[Not Available]	None	[Not Available]	63	Atypical Mitotic Figures Present	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Absent
185	TCGA-PK-A5HB	MALE	[Unknown]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	63	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]
186	TCGA-PK-A5HC	FEMALE	ASIAN	YES	[Not Available]	[Not Available]	YES	YES	Vena Cava Involvement/thrombus	[Discrepancy]	19	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	44	[Not Available]	Cytoplasm presence <= 25% Present	Diffuse Architecture Present	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	Venous Invasion Present
